Zhejiang Medicine Co (SHSE:600216) Moat Score: 0/10 (As of Jul. 13, 2026)


SHSE:600216 Zhejiang Medicine Co Ltd SHSE:600216
81 GF Score
Price ¥11.89
GF Value ¥13.82
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Zhejiang Medicine Co Moat Score?

Zhejiang Medicine Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Zhejiang Medicine Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Zhejiang Medicine Co might have No Moat - No discernible moat.

Zhejiang Medicine Co  (SHSE:600216) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Zhejiang Medicine Co Moat Score Related Terms

SHSE:600216
81GF Score
Zhejiang Medicine Co Ltd SHSE:600216
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Medicine Co (SHSE:600216) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Medicine Co stock appears to be undervalued. The current stock price of ¥11.89 is trading 14% below its estimated GF Value™ of ¥13.82. GuruFocus considers Zhejiang Medicine Co to be Modestly Undervalued.

Key valuation signals for SHSE:600216:

  • Moat Score: 0
  • GF Value™: ¥13.82 vs. price of ¥11.89 (14% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600216 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Medicine Co Business Description

Address Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
81GF Score

Get the complete analysis for SHSE:600216

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.89
Price
¥13.82
GF Value